Skip to content

Leidos

US · LDOS #1114 by market cap Listed 1970
122.21 -2.55 -2.04%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Fair Value how this is computed

Near fair value
35.05 fair value ≈ 319.46 603.88
  • Implied fair-value range of 35.05-603.88, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is -61.7% below the average-multiple fair value of 319.46.

Valuation each multiple against its own 5-year range

P/B ratio 2.88 Cheap vs history 12th percentile
5-year average 3.79 · #53 of 76 in Information Technology Services
P/E ratio 10.92 Cheap vs history 3rd percentile
5-year average 28.68 · forward 11.49 · #11 of 39 in Information Technology Services
P/S ratio 0.84 Cheap vs history 6th percentile
5-year average 1.07 · forward 0.81 · #32 of 80 in Information Technology Services

Vs. peers Information Technology Services

Company Market cap P/E (TTM) P/B Div yield
Leidos (LDOS) 14.91B 10.92 2.88 1.41%
IBM Corp (IBM) 212.12B 19.10 5.97 3.00%
Accenture (ACN) 131.82B 16.31 4.18 2.95%
Infosys (INFY) 48.73B 15.04 4.72 4.36%
Fiserv (FISV) 29.73B -7.56 1.41 0.00%
Cognizant (CTSH) 25.95B 10.59 1.76 2.24%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value160.92 Economic moatNarrow UncertaintyLow

Trading 31.7% below Morningstar's fair value estimate.

Fair value

Given the significant price pressure over the last year, Leidos Holdings Inc might appear cheap. However, to account for the possibility that it may be a value trap, we've restricted its rating to 3 stars. The stock currently trades at a 22% discount to our quantitative fair value estimate of $160.92 per share, which is reinforced by this estimate's low uncertainty rating.

The company's profitability bolsters our valuation estimate. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. For example, the firm's sales yield of 107.3% sits in the top 40% compared with global peers. This company has a robust ability to generate sales without much capital investment, freeing up more capital to be returned to shareholders in the long run. We believe this is a sign that shares could be undervalued.

The firm's valuation metrics are an additional encouraging factor. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to revenue ratio of 1.2, a core component of valuation, falls in the bottom 40% compared with global peers. The prevailing enterprise value/sales ratio is low relative to the long-term earnings power of the business. This characteristic further promotes our favorable price/fair value ratio.

Economic moat

The company's narrow quantitative moat rating indicates it could outearn its cost of capital and maintain robust margins for 10 years or longer. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

By Quantitative Equity Report

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Leidos discussion 0 comments

Add a comment